Bioavailability Study of Magne-B6 New Formulation

Trial Identifier:	BDR17228
Sponsor:	Opella Healthcare Group SAS, a Sanofi Company
Start Date:	July 2024
Primary Completion Date:	August 2024
Study Completion Date:	August 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Turkey	Kayseri, Turkey, 38039

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.